Got $5,000? Hims & Hers Could Be a Direct‑to‑Consumer Health Moonshot in the Making
The Motley Fool
by newsfeedback@fool.com (Reuben Gregg Brewer)February 27, 2026
Hims & Hers is facing some well-deserved pushback from Novo Nordisk, but the big picture is still promising.
Verticals
financeinvesting
Originally published on The Motley Fool on 2/27/2026